Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bryant

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|September 8, 2004
Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trialsBernard Fisher, Jong-Hyeon Jeong, John Bryant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Association of tamoxifen and uterine sarcomaD Lawrence Wickerham, Bernard Fisher, Norman Wolmark, et al.
Cells|October 23, 2021
Meristematic Connectome: A Cellular Coordinator of Plant Responses to Environmental Signals?Donato Chiatante, Antonio Montagnoli, Dalila Trupiano, et al.
Journal of the National Cancer Institute|December 2, 2004
Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifenWorta McCaskill-Stevens, John Wilson, John Bryant, et al.
Acta Oncologica (Stockholm, Sweden)|December 7, 2019
Minimal acute toxicity from proton beam therapy for major salivary gland cancerMichael Chuong, John Bryant, William Hartsell, et al.
Journal of Electronic Materials|June 10, 2025
Catalytic Degradation of Organic Dyes Indicates Anti-Proliferative Effects of Magnetoelectric NanoparticlesMax Shotbolt, Emily Zhu, Victoria Andre, et al.
The New England Journal of Medicine|October 24, 2002
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancerBernard Fisher, Stewart Anderson, John Bryant, et al.
Journal of the National Cancer Institute|April 8, 2004
Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancerSandra M Swain, John W Wilson, Eleftherios P Mamounas, et al.
Annals of Surgical Oncology|March 17, 2004
NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trialDavid N Krag, Thomas B Julian, Seth P Harlow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2005
Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28Eleftherios P Mamounas, John Bryant, Barry Lembersky, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|September 8, 2004
Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trialsBernard Fisher, Jong-Hyeon Jeong, John Bryant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Association of tamoxifen and uterine sarcomaD Lawrence Wickerham, Bernard Fisher, Norman Wolmark, et al.
Cells|October 23, 2021
Meristematic Connectome: A Cellular Coordinator of Plant Responses to Environmental Signals?Donato Chiatante, Antonio Montagnoli, Dalila Trupiano, et al.
Journal of the National Cancer Institute|December 2, 2004
Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifenWorta McCaskill-Stevens, John Wilson, John Bryant, et al.
Acta Oncologica (Stockholm, Sweden)|December 7, 2019
Minimal acute toxicity from proton beam therapy for major salivary gland cancerMichael Chuong, John Bryant, William Hartsell, et al.
Journal of Electronic Materials|June 10, 2025
Catalytic Degradation of Organic Dyes Indicates Anti-Proliferative Effects of Magnetoelectric NanoparticlesMax Shotbolt, Emily Zhu, Victoria Andre, et al.
The New England Journal of Medicine|October 24, 2002
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancerBernard Fisher, Stewart Anderson, John Bryant, et al.
Journal of the National Cancer Institute|April 8, 2004
Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancerSandra M Swain, John W Wilson, Eleftherios P Mamounas, et al.
Annals of Surgical Oncology|March 17, 2004
NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trialDavid N Krag, Thomas B Julian, Seth P Harlow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2005
Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28Eleftherios P Mamounas, John Bryant, Barry Lembersky, et al.
Pageof 8